Filter
2503
Filtered Results: 2503
Text search:
Depar
tment
of
Health,
National
Center
for
Disease
Prevention
and
Control
Featured
Recommendations
196
New Publications
661
Language
Document type
No document type
1492
Studies & Reports
428
Guidelines
306
Manuals
126
Strategic & Response Plan
78
Training Material
28
Situation Updates
21
Fact sheets
17
Resource Platforms
3
Infographics
3
App
1
Countries / Regions
India
128
Global
80
Ethiopia
67
Kenya
64
Liberia
60
Nepal
57
Philippines
48
Latin America and the Carribbean
48
Nigeria
42
Uganda
40
Rwanda
39
Africa
39
Sierra Leone
37
Malawi
35
Myanmar / Burma
34
Western and Central Europe
32
Zambia
29
Tanzania
29
Ukraine
29
South Africa
25
Bangladesh
25
Cambodia
24
Ghana
23
Asia
22
Eastern Europe
21
Russia
19
Senegal
18
Haiti
18
Indonesia
17
Mozambique
17
Congo, Democratic Republic of
15
Namibia
15
South–East Asia Region
15
Guinea
14
USA
13
Zimbabwe
12
South Sudan
12
Brazil
12
Lesotho
12
Syria
11
Colombia
11
Thailand
9
Burkina Faso
8
Botswana
8
West and Central Africa
8
Middle East and North Africa
8
Eastern Europe and Central Asia
8
Albania
8
Pakistan
7
East and Southern Africa
7
Germany
6
Yemen
6
Georgia
6
Vietnam
6
Afghanistan
5
Peru
5
Western Pacific Region
5
Paraguay
5
Venezuela
5
Laos
5
Moldova
5
Somalia
4
China
4
Benin
4
Eswatini/ Swaziland
4
Bolivia
4
Sri Lanka
4
Armenia
4
Tajikistan
4
North America
4
Mali
3
Cameroon
3
Jordan
3
Turkey
3
North Macedonia
3
Ecuador
3
Angola
3
Chile
3
Belarus
3
Malaysia
2
Argentina
2
Honduras
2
Mexico
2
Southern Africa
2
Canada
2
Timor Leste/ East Timor
2
Romania
2
Japan
2
United Kingdom
2
Spain
2
Guinea-Bissau
1
Côte d’Ivoire / Ivory Coast
1
Iraq
1
Egypt
1
Papua New Guinea
1
Central African Republic
1
Hungary
1
Burundi
1
El Salvador
1
Libya
1
Madagascar
1
Other region
1
Bhutan
1
Poland
1
Palestine
1
Mongolia
1
Qatar
1
Estonia
1
Lithuania
1
Iran
1
Kyrgyzstan
1
Kazakhstan
1
Gabon
1
Turkmenistan
1
Belgium
1
France
1
Mauritius
1
Portugal
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
919
Clinical Guidelines
204
Public Health
150
Women & Child Health
111
Key Resources
93
Capacity Building
41
Pharmacy & Technologies
25
Toolboxes
HIV
236
Mental Health
218
COVID-19
181
TB
158
AMR
114
Rapid Response
81
Ebola
78
Planetary Health
78
NTDs
68
Disability
60
Caregiver
59
NCDs
57
Global Health Education
42
Pharmacy
37
Conflict
36
Refugee
36
Zika
30
Natural Hazards
28
Health Financing Toolbox
22
Specific Hazards
20
Cholera
11
Polio
8
Social Ethics
4
Typhoon
2
South Sudan
1
Health Financing
1
Original Research
African Journal of Primary Health Care & Family Medicine
ISSN: (Online) 2071-2936, (Print) 2071-2928
Open Access
national programmes for occupational health and safety ... health workers: lessons learned from countries: summary report of the WHO online workshop, 15 July 2020
This publication is a companion document to the NDVP National Deployment and Vaccination Plans guidance, which provides a framework for countries ...
The United States Agency for International Development (USAID) Bureau for Democracy, Conflict, and Humanitarian Assistance Office ... U.S. Foreign Disaster Assistance (DCHA/OFDA) requested Food and Nutrition Technical Assistance II Project (FANTA-2) assistance to review Community-Based Management of Acute Malnutrition (CMAM) in four West African countries—Burkina Faso, Mali, Mauritania, and Niger—to help identify DCHA/OFDA 2010 and 2011 program priorities, including where DCHA/OFDA investment should be directed to support CMAM. The goal was to review CMAM program implementation and its integration into national health systems to provide DCHA/OFDA a status report for each country; draw lessons learned; and make recommendations on challenges, promising practices, gaps, and priority areas for DCHA/OFDA support during 2010 and 2011. The review was intended for DCHA/OFDA program planning purposes and also potentially as an advocacy tool to guide other donors in planning CMAM support in the region. After all four countries have been reviewed, FANTA-2 will develop a synthesis report. The current document presents a summary report on CMAM in Burkina Faso only.
Terminology used to describe the transmission of pathogens through the air varies across scientific disciplines, organizations and the general public. While this has been the case ... decades, during the coronavirus disease (COVID-19) pandemic, the terms ‘airborne’, ‘airborne transmission’ and ‘aerosol transmission’ were used in different ways by stakeholders in different scientific disciplines, which may have contributed to misleading information and confusion about how pathogens are transmitted in human populations.
This global technical consultation report brings together viewpoints from experts spanning a range of disciplines with the key objective of seeking consensus regarding the terminology used to describe the transmission of pathogens through the air that can potentially cause infection in humans.
This consultation aimed to identify terminology that could be understood and accepted by different technical disciplines. The agreed process was to develop a consensus document that could be endorsed by global agencies and entities. Despite the complex discussions and challenges, significant progress was made during the consultation process, particularly the consensus on a set of descriptors to describe how pathogens are transmitted through the air and the related modes of transmission. WHO recognizes the important areas where consensus was not achieved and will continue to address these areas in follow-up consultations.
This toolkit is designed to help you plan and implement a Patient Navigation program with the best chance of reducing health disparities ... improving health outcomes for your patients. It contains evidence-based and experience-based examples, case studies, practical tools, and resources to help you:
1. Establish an evidence-based patient navigation program tailored to reduce barriers for your patients
2. Incorporate best practices to enhance current patient navigation programs or services
3. Implement a patient navigation model to address any targeted medical condition
where disparities exist
4. Hire, prepare, supervise, support and retain effective Patient Navigators
5. Navigate patients who experience health disparities
6. Evaluate patient navigation programs with the aim of continuous quality
improvement
Alcohol contributes significantly to the disease and mortality burden in the WHO European Region, and primary ... care systems play an important role in reducing the impact of harmful alcohol use. Screening and brief interventions (SBIs) for alcohol are an evidence-informed approach to addressing the needs of the many patients presenting in primary care who may benefit from reducing their alcohol consumption. This manual provides information to plan training and support for primary care practitioners to confidently deliver SBI for alcohol problems to their patients. The manual outlines the background and evidence base for SBI, and gives practical advice on establishing an implementation programme as well as detailed educational materials to develop the knowledge and skills of participants in organized training sessions.
Disinfection of drinking-water supplies has been one of the most significant public health advancements ... the last century with respect to reducing waterborne disease.
Although chlorine has been used as the disinfectant of choice for public drinking-water supplies for the past century, a number of emerging or alternative compounds are used or are being considered for the disinfection of drinking-water.
This series reviews the state of the knowledge on the application, efficacy and toxicity of bromine, iodine and silver as drinking-water disinfectants.
Although chlorine has been used as the disinfectant of choice for public drinking-water supplies for the past century, a number of emerging or alternative compounds are used or are being considered for the disinfection of drinking-water.
This series reviews the state of the knowledge on the application, efficacy and toxicity of bromine, iodine and silver as drinking-water disinfectants.
In light of the decline in new Ebola cases, strategies are now needed to scale down the activities and bed capacities in Ebola care facilities. These facilities include Ebola treatment units, commun...
Childhood Respiratory Diseases & the Environment learning objectives
•To understand how the respiratory tract is affected by the environment
•To describe respiratory diseases linked to the ...
The KMC implementation strategy targets a broad audience. These include policy-makers and programme managers at national, regional and local levels...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable ... (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
The State of the world’s nursing 2020 report provides the latest, most up-to-date evidence on and policy options for the global nursing workforce...
NAMI HelpLine
Contents
I’m having a lot of anxiety because of the coronavirus. Please help.
I’m quarantined or working from home – lonely an... isolated even further – what can I do?
I don’t have health insurance or a regular doctor – how can I get care?
What if I’m quarantined and can’t get my medication? Will there be a shortage?
My business is suffering as a result of the Coronavirus. What assistance programs are available to help?
Are people who have a mental illness at a greater risk of contracting COVID-19?
Is there a vaccine or cure for COVID-19?
I lost a loved one to Coronavirus. Where can I find support?
I’m a smoker. Am I more likely to catch COVID-19? What should I do?
How does homelessness increase risk of contracting COVID-19?
My loved one is incarcerated, are they at increased risk for exposure to COVID-19?
I’m the aging parent of an adult child living with a serious mental illness. I want to be sure they are taken care of.
Are there any online support resources for people with substance use disorders?
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable ... (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
First published in 2020, this toolkit is intended for clinicians working in acute care, managing adult and paediatric patients with acute respiratory infection, including severe pneumonia, acute res...
This guideline provides global, evidence-informed recommendations on daily iron supplementation in infants and children, as a public-health intervention f... the prevention of anaemia and iron deficiency. It includes recommendations for iron supplementation in countries where malaria is prevalent.
